Login / Signup

High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV.

Hiroaki SasakiNobuyuki MiyataYukihiro YoshimuraNatsuo Tachikawa
Published in: Infection (2022)
supports the clinical benefit of therapeutic and prophylactic use of REGN-COV from the serological point of view.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • amino acid
  • dengue virus
  • binding protein
  • mesenchymal stem cells
  • small molecule
  • replacement therapy